Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Weight Loss 2Prostatic Neoplasms 2Obesity 2Urinary Bladder Neoplasms 1Polycystic Ovary Syndrome 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lung Neoplasms 1Diabetes Mellitus 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Diet, Carbohydrate-Restricted × Clear all
NCT05090358 2025-10-27

Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
15 enrolled
Breast

Breast Neoplasms

NCT02744079 2020-08-31

KetoBreast

Albert Einstein College of Medicine

Phase NA Completed
11 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT01559194 2014-04-14

LEAF

Ohio State University Comprehensive Cancer Center

Phase 3 Completed
82 enrolled
Breast

Breast Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡